個案資料
了解個案內容與學習目標，選擇授課教師及使用課程。
Metagenom Bio Inc: Protecting Intellectual Property Rights in China
內容大綱
This case deals with the planned market expansion of Metagenom Bio Inc. (MBI), a Canadian microbiome company that specializes in designing and structuring novel environmental monitoring and remediation technology and processes. The case revolves around the situation in 2019 facing Patrick Ang, the CEO of MBI, who has to take strategic decisions at a crucial point of MBI's development of a potential entry to China while keeping confidential the details of the IP of MBI.